RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
2 CLASSES OF CAMP ANALOGS SYNERGISTICALLY INHIBIT P21 RAS PROTEIN-SYNTHESIS AND PHENOTYPIC TRANSFORMATION OF NIH/3T3 CELLS TRANSFECTED WITH HA-MUSV DNA
1985-01-01 Tagliaferri, P; Clair, T; Debortoli, Me; Chochung, Ys
5-AZA-2'-DEOXYCYTIDINE INDUCES GROWTH-INHIBITION AND UP-REGULATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR ON HUMAN EPITHELIAL CANCER-CELLS
1994-01-01 Caraglia, M; Pinto, A; Correale, P; Zagonel, V; Genua, G; Leardi, A; Pepe, S; Bianco, Ar; Tagliaferri, P
8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor
1999-01-01 Budillon, A; DI GENNARO, E; Caraglia, M; Barbarulo, D; Abbruzzese, A; Tagliaferri, P
90K IS A SERUM MARKER OF POOR-PROGNOSIS IN NON-HODGKINS-LYMPHOMA PATIENTS
1994-01-01 Rea, A; Palmieri, G; Tinari, N; Natoli, C; Tagliaferri, P; Morabito, A; Grassadonia, A; Bianco, Ar; Iacobelli, S
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells in vitro
2014-01-01 Leotta, M; Biamonte, L; Raimondi, L; Ronchetti, D; Martino, Mt; Botta, C; Leone, E; Pitari, Mr; Neri, A; Giordano, A; Tagliaferri, P; Amodio, N; Tassone, P
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
2016-01-01 Gulla', A; Di Martino, Mt; Gallo Cantafio, Me; Morelli, E; Amodio, N; Botta, C; Pitari, Mr; Lio, Sg; Stamato, Ma; Hideshima, T; Munshi, Nc; Anderson, Kc; Tagliaferri, P; Tassone, P; Britti, Domenico
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation
2008-01-01 Cascinu, S; Berardi, R; Salvagni, S; Beretta, Gd; Catalano, V; Pucci, F; Sobrero, A; Tagliaferri, P; Labianca, R; Scartozzi, M; Crocicchio, F; Mari, E; Ardizzoni, A
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine.
2019-01-01 Catalano, R; Rocca, Roberta; Juli, Giada; Costa, Giosuè; Maruca, A; Artese, A; Caracciolo, D; Tagliaferri, P; Alcaro, S; Tassone, P; Amodio, N.
A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival
2016-01-01 Botta, C; Di Martino, Mt; Ciliberto, D; Cucè, M; Correale, P; Tagliaferri, P; Tassone, P; Rossi, M
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells
2022-01-01 Riillo, Caterina; Caracciolo, Daniele; Grillone, Katia; Polerà, Nicoletta; Tuccillo, Franca Maria; Bonelli, Patrizia; Juli, Giada; Ascrizzi, Serena; Scionti, Francesca; Arbitrio, Mariamena; Lopreiato, Mariangela; Siciliano, Maria Anna; Sestito, Simona; Talarico, Gabriella; Galea, Eulalia; Galati, Maria Concetta; Pensabene, Licia; Loprete, Giovanni; Rossi, Marco; Ballerini, Andrea; Gentile, Massimo; Britti, Domenico; Di Martino, Maria Teresa; Tagliaferri, Pierosandro; Tassone, Pierfrancesco
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
2 CLASSES OF CAMP ANALOGS SYNERGISTICALLY INHIBIT P21 RAS PROTEIN-SYNTHESIS AND PHENOTYPIC TRANSFORMATION OF NIH/3T3 CELLS TRANSFECTED WITH HA-MUSV DNA | 1-gen-1985 | Tagliaferri, P; Clair, T; Debortoli, Me; Chochung, Ys | |
5-AZA-2'-DEOXYCYTIDINE INDUCES GROWTH-INHIBITION AND UP-REGULATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR ON HUMAN EPITHELIAL CANCER-CELLS | 1-gen-1994 | Caraglia, M; Pinto, A; Correale, P; Zagonel, V; Genua, G; Leardi, A; Pepe, S; Bianco, Ar; Tagliaferri, P | |
8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor | 1-gen-1999 | Budillon, A; DI GENNARO, E; Caraglia, M; Barbarulo, D; Abbruzzese, A; Tagliaferri, P | |
90K IS A SERUM MARKER OF POOR-PROGNOSIS IN NON-HODGKINS-LYMPHOMA PATIENTS | 1-gen-1994 | Rea, A; Palmieri, G; Tinari, N; Natoli, C; Tagliaferri, P; Morabito, A; Grassadonia, A; Bianco, Ar; Iacobelli, S | |
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells in vitro | 1-gen-2014 | Leotta, M; Biamonte, L; Raimondi, L; Ronchetti, D; Martino, Mt; Botta, C; Leone, E; Pitari, Mr; Neri, A; Giordano, A; Tagliaferri, P; Amodio, N; Tassone, P | |
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells | 1-gen-2016 | Gulla', A; Di Martino, Mt; Gallo Cantafio, Me; Morelli, E; Amodio, N; Botta, C; Pitari, Mr; Lio, Sg; Stamato, Ma; Hideshima, T; Munshi, Nc; Anderson, Kc; Tagliaferri, P; Tassone, P; Britti, Domenico | |
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation | 1-gen-2008 | Cascinu, S; Berardi, R; Salvagni, S; Beretta, Gd; Catalano, V; Pucci, F; Sobrero, A; Tagliaferri, P; Labianca, R; Scartozzi, M; Crocicchio, F; Mari, E; Ardizzoni, A | |
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. | 1-gen-2019 | Catalano, R; Rocca, Roberta; Juli, Giada; Costa, Giosuè; Maruca, A; Artese, A; Caracciolo, D; Tagliaferri, P; Alcaro, S; Tassone, P; Amodio, N. | |
A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival | 1-gen-2016 | Botta, C; Di Martino, Mt; Ciliberto, D; Cucè, M; Correale, P; Tagliaferri, P; Tassone, P; Rossi, M | |
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells | 1-gen-2022 | Riillo, Caterina; Caracciolo, Daniele; Grillone, Katia; Polerà, Nicoletta; Tuccillo, Franca Maria; Bonelli, Patrizia; Juli, Giada; Ascrizzi, Serena; Scionti, Francesca; Arbitrio, Mariamena; Lopreiato, Mariangela; Siciliano, Maria Anna; Sestito, Simona; Talarico, Gabriella; Galea, Eulalia; Galati, Maria Concetta; Pensabene, Licia; Loprete, Giovanni; Rossi, Marco; Ballerini, Andrea; Gentile, Massimo; Britti, Domenico; Di Martino, Maria Teresa; Tagliaferri, Pierosandro; Tassone, Pierfrancesco |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 312
- 1 Contributo su Rivista::1.1 Arti... 298
- 1 Contributo su Rivista::1.5 Abst... 14
Data di pubblicazione
- 2020 - 2023 39
- 2010 - 2019 141
- 2000 - 2009 77
- 1990 - 1999 43
- 1985 - 1989 12
Rivista
- ONCOTARGET 14
- BLOOD 11
- CANCER BIOLOGY & THERAPY 11
- CLINICAL CANCER RESEARCH 11
- CANCERS 10
- EUROPEAN JOURNAL OF CANCER 8
- CELL DEATH AND DIFFERENTIATION 7
- INTERNATIONAL JOURNAL OF CANCER 7
- INTERNATIONAL JOURNAL OF ONCOLOGY 7
- LEUKEMIA 7
Keyword
- multiple myeloma 10
- Humans 6
- immunotherapy 6
- microRNA 6
- Multiple Myeloma 6
- Multiple myeloma 6
- Apoptosis 5
- cancer 5
- miRNA 5
- Gene Expression Regulation 4
Lingua
- eng 203
- ita 2
Accesso al fulltext
- no fulltext 312